NDOW:BATS-Anydrus Advantage ETF (USD)

ETF | Others |

Last Closing

USD 24.76

Change

+0.09 (+0.36)%

Market Cap

USD 0.04B

Volume

6.45K

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-03-24 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
FBTC Fidelity Wise Origin Bitcoin T..

+0.40 (+0.53%)

USD 16.66B
INDA iShares MSCI India ETF

+0.39 (+0.76%)

USD 8.63B
PAVE Global X U.S. Infrastructure D..

-0.31 (-0.80%)

USD 8.48B
BUFR First Trust Cboe Vest Fund of ..

-0.08 (-0.27%)

USD 6.45B
BOXX Alpha Architect 1-3 Month Box ..

+0.04 (+0.04%)

USD 5.42B
BBUS JPMorgan BetaBuilders U.S. Equ..

-0.38 (-0.37%)

USD 4.20B
ARKB ARK 21Shares Bitcoin ETF

+0.53 (+0.61%)

USD 3.92B
KNG FT Cboe Vest S&P 500® Dividen..

-0.14 (-0.28%)

USD 3.66B
GSUS Goldman Sachs MarketBeta US Eq..

-0.35 (-0.45%)

USD 2.47B
IFRA iShares U.S. Infrastructure ET..

-0.27 (-0.59%)

USD 2.19B

ETFs Containing NDOW

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 1.83% 79% B- 76% C+
Dividend Return N/A N/A N/A N/A N/A
Total Return 1.83% 79% B- 76% C+
Trailing 12 Months  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) N/A N/A N/A N/A N/A
Risk Adjusted Return N/A N/A N/A N/A N/A
Market Capitalization 0.04B 51% F 45% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike